43 filings
6-K
MITO
Stealth BioTherapeutics Corp
16 Nov 22
Stealth BioTherapeutics Corp Announces Completion of Merger
4:08pm
6-K
MITO
Stealth BioTherapeutics Corp
7 Oct 22
Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders
4:10pm
6-K
MITO
Stealth BioTherapeutics Corp
30 Sep 22
Current report (foreign)
5:10pm
6-K
MITO
Stealth BioTherapeutics Corp
19 Aug 22
Current report (foreign)
4:15pm
6-K
MITO
Stealth BioTherapeutics Corp
1 Aug 22
Stealth BioTherapeutics Corp Enters Definitive Agreement for Going Private Transaction
8:38am
6-K
g3u35 57wjuo
11 Jul 22
Stealth Biotherapeutics Announces Receipt of Non-compliance Notice from Nasdaq
5:20pm
6-K
kbimx3sdhieiz
27 Jun 22
Stealth BioTherapeutics Corp Announces Receipt of Preliminary
8:02am
6-K
vk421f osawuj7rc1bk
18 May 22
Current report (foreign)
8:16am
6-K
vkya1
11 Apr 22
Current report (foreign)
8:41am
6-K
97uihjjyurq2gramhr
18 Mar 22
Current report (foreign)
4:46pm
6-K
23on1jxravgaz
14 Feb 22
Stealth Biotherapeutics Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Requirement
12:00am
6-K
ahsmom158zoo8ym
7 Jan 22
Stealth Biotherapeutics Receives Nasdaq Notifications Regarding Minimum Bid and Market Value Requirements
4:40pm
6-K
et1wc9kzgy5
12 Nov 21
Stealth Biotherapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights
8:15am
6-K
lc93i k08jzezc
20 Oct 21
Current report (foreign)
7:50am
6-K
kryag m25
4 Oct 21
Current report (foreign)
7:45am
6-K
sgsz aaxi46d
5 Aug 21
Current report (foreign)
4:47pm
6-K
37htr7b
5 Aug 21
Stealth Biotherapeutics Reports Second Quarter 2021 Financial Results and Recent Business Highlights
8:10am
6-K
qfg3c bteg
20 Jul 21
6-K Annual Meeting Results
4:11pm
6-K
5luci1gr9xvjns4lq1x
15 Jun 21
6-K for Annual Proxy
4:30pm
6-K
ub3hw0y
18 May 21
Stealth Biotherapeutics Announces Additional Development Financing to Advance Elamipretide Clinical Trials
8:21am